News Home

Inotiv Inc Up 25.81% To $26.08 After Earnings Miss

Thursday, August 11, 2022 11:34 AM | InvestorsObserver Analysts

Mentioned in this article

Inotiv Inc Up 25.81% To $26.08 After Earnings Miss

Inotiv Inc (NOTV) said after close Wednesday that it lost $0.15 per share in quarter three 2022.

On the revenue line, the company reported $172.7 million, beating estimates by $30.9 million.

In the same quarter a year ago, the company lost $0.15 per share on revenue of $22.9 million.

The stock is up 25.81% to $26.08 after the report.

The average recommendation from Wall Street analysts was a Strong Buy which may get revised based on this new data.

Trading in the five days leading up to the report earned Inotiv Inc a Bullish Sentiment Rank from InvestorsObserver.

Prior to the report, InvestorsObserver gave the stock an overall score of 65. Meanwhile, the average Wall Street analyst rated the stock a Strong Buy.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. It operates in two principal segments - Research services and Research products.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App